understanding-menopause
 
 

To determine the proper treatment for your hot flashes, your doctor needs to know how severe they are.

Complete these few questions accurately. Print the results out with your answers, and take them with you when you go to the doctor to discuss your symptoms. When you print your results, you will also receive a money savings coupon for your Elestrin prescriptions.

Answer honestly so your doctor has an accurate picture of your symptoms. If the choices don’t describe you exactly, choose the answer that is most accurate.

1. How many months has it been since your last period?

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10

2. About how many times during the day and night do you experience hot flashes?

  • 1 - 5
  • 6 - 10
  • 11 - 15
  • Over 15

3. How would you describe the severity of your hot flashes?

  • Mild
  • Moderate
  • Severe

4. How much do your hot flashes interfere with your everyday life?

  • Not much
  • Somewhat
  • Quite a bit

5. About how many times during the night do you experience night sweats?

  • 1 or less
  • 1 - 5
  • 5 - 10
  • Over 10

6. How would you describe the severity of your night sweats?

  • Mild
  • Moderate
  • Severe

7. How much do your night sweats interfere with your sleep?

  • Not much
  • Somewhat
  • Quite a bit

8. How much would you say your hot flashes and night sweats are negatively affecting your life?

  • Not much
  • Somewhat
  • Quite a bit

9. What have you done to try to control your hot flashes and night sweats?

  • Nothing
  • Diet
  • Exercise
  • Medication

You’ve taken a valuable step toward controlling your vasomotor symptoms by completing this assessment. Print the results and take them to your doctor to discuss your treatment.

 
 

Important Safety InformationElestrin is indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.

Estrogens, with or without progestins, should not be used for the prevention of cardiovascular disease or dementia. Estrogen and progestin therapy has shown an increased risk of breast cancer, heart attack, and blood clots. Estrogen therapy, with or without progestins, increases the risk of stroke and dementia. Estrogen therapy alone increases the risk of endometrial cancer. The most frequently reported adverse events in clinical trials were nasopharyngitis, breast tenderness, upper respiratory tract infection, and metrorrhagia.

Please see Full Prescribing Information, including Black Box Warning

 
 

Close (x)

A Survey of 300 untreated menopausal women reveal what they want from the application of transdermal estrogen therapy†:

"I want a product I can apply and forget it."

"I’d rather just rub the product in and forget it’s there."

"For me, it’s easier to get into a daily habit."

"I like the control of applying [it] right on my upper arm."

"Make it clear and easy to apply."

†A blinded survey of 300 women with hot flashes to evaluate the importance of various attributes of transdermal estrogen therapy and the preference for various topical estrogen therapy products. Azur Pharma; 2009.